PubMed: Δ<sup>9</sup>-<em>cis</em>-Tetrahydrocannabinol: Natural Occurrence, Chirality, and Pharmacology
J Nat Prod. 2021 Jul 25. doi: 10.1021/acs.jnatprod.1c00513. Online ahead of print.
The cis-stereoisomers of Δ9-THC [(-)-3 and (+)-3] were identified and quantified in a series of low-THC-containing varieties of Cannabis sativa registered in Europe as fiber hemp and in research accessions of cannabis. While Δ9–cis-THC (3) occurs in cannabis fiber hemp in the concentration range of (-)-Δ9–trans-THC [(-)-1], it was undetectable in a sample of high-THC-containing medicinal cannabis. Natural Δ9–cis-THC (3) is scalemic (ca. 80-90% enantiomeric purity), and the absolute configuration of the major enantiomer was established as 6aS,10aR [(-)-3] by chiral chromatographic comparison with a sample available by asymmetric synthesis. The major enantiomer, (-)-Δ9–cis-THC [(-)-3], was characterized as a partial cannabinoid agonist in vitro and elicited a full tetrad response in mice at 50 mg/kg doses. The current legal discrimination between narcotic and non-narcotic cannabis varieties centers on the contents of “Δ9-THC and isomers” and needs therefore revision, or at least a more specific wording, to account for the presence of Δ9–cis-THCs [(+)-3 and (-)-3] in cannabis fiber hemp varieties.
#CBD #Hemp https://pubmed.ncbi.nlm.nih.gov/34304557/?utm_source=Chrome&utm_medium=rss&utm_campaign=None&utm_content=1jYCQzi_o_qLYr-oQfnMhShgOXkvGma3vcnBGJtrBhuJMOvEVJ&fc=None&ff=20210726065926&v=2.14.5 July 26, 2021 10:00 am